Thyroid Hormone Inactivation in Gastrointestinal Stromal Tumors
Michelle Maynard(Blueprint Medicines (United States)), Stephen A. Huang(Brigham and Women's Hospital), Mary C. Frates(Brigham and Women's Hospital), Adrián Mariño‐Enríquez(Harvard University Press), P. Reed Larsen(Brigham and Women's Hospital), Chandrajit P. Raut(Brigham and Women's Hospital), Leila Yassa(Newton Wellesley Hospital), Clara Dorfman(Noguchi Thyroid Clinic and Hospital Foundation), Rebecca H. Jugo(Noguchi Thyroid Clinic and Hospital Foundation), Takahiro Taguchi(Kochi Medical School Hospital), Huai‐Dong Song(Shanghai Jiao Tong University), Yuexiang Wang(Shanghai Institute of Nutrition and Health), Jerome M. Hershman(University of California, Los Angeles), Jonathan A. Fletcher(Brigham and Women's Hospital), Henry A. Feldman, Cuicui Guo(Noguchi Thyroid Clinic and Hospital Foundation), David M. Dorfman(Brigham and Women's Hospital)
Cited by 71
Related Papers
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2002|1.8k
Subclinical Thyroid Disease
|JAMA|2004|1.8k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k
Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*
|The Journal of Clinical Endocrinology & Metabolism|1991|1.1k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716